Dexcom (DXCM)

Stock-Based Compensation

$39.00M

Quarterly · Period ending: · USD

DXCM logo

DXCM Stock-Based Compensation

Latest reported$39.00M
DXCM Quarterly Stock-Based Comp ($581.12K → $39.00M)
High-resolution chart · PNG

DXCM stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
39,000,000
43,300,000
35,000,000
45,100,000
45,300,000
34,200,000
43,300,000
43,400,000
44,700,000
39,000,000
36,900,000
39,000,000
39,700,000
35,200,000
34,000,000
30,800,000
32,600,000
29,100,000
26,300,000
27,500,000
31,600,000
28,000,000
34,100,000
30,700,000
30,700,000
23,900,000
23,600,000
24,400,000
29,700,000
25,000,000
24,600,000
27,100,000
25,600,000
24,600,000
24,900,000
25,400,000
25,300,000
30,600,000
29,100,000
29,000,000
27,600,000
25,100,000
23,500,000
22,600,000
20,700,000
15,900,000
14,300,000
13,800,000
13,200,000
8,700,000
6,600,000
6,600,000
6,400,000
5,000,000
4,542,000
4,879,000
4,833,000
4,146,000
3,580,000
3,728,000
3,657,000
2,548,000
-7,363,000
2,317,000
2,771,000
2,275,000
2,154,000
2,130,000
2,041,000
2,041,000
0
0
0
1,948,000
6,122,000
0
0
1,096,000
5,852,901,000
402,841
480,574
1,288,768,000
1,665,572,000
0
0
581,123
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.